Pulmonary hypertension in hemolytic anemias

F1000 Medicine Reports

Volumn 2, Issue 1, 2010, Pages

  Wahl, Shannon ^a   Vichinsky, Elliott ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

CLINICAL PRACTICE; ENDOTHELIAL DYSFUNCTION; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; RISK ASSESSMENT; SICKLE CELL ANEMIA; THALASSEMIA;

EID: 77955073999     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M2-10     Document Type: Review

References (49)

1. Vichinsky EP: Pulmonary hypertension in sickle cell disease. N Engl J Med 2004, 350:857-9.
2. Bachmeyer C, Khalil A, Kerrou K, Girot R, Gounant V: Idiopathic pulmonary arterial hypertension in a patient with pyruvate kinase deficiency and paravertebral extramedullary hematopoiesis. Ann Hematol 2009, 88:603-5.
3. Connor P, Veys P, Amrolia P, Haworth S, Ashworth M, Moledina S: Pulmonary hypertension in children with Evans syndrome. Pediatr Hematol Oncol 2008, 25:93-8. (Pubitemid 351431226)
4. Lode HN, Krings G, Schulze-Neick I, Dahmlow S, Schroeder U, Bonnet R, DaPalma J, Luck W, Strauss G, Berger F, Gaedicke G: Pulmonary hypertension in a case of Hb-Mainz hemolytic anemia. J Pediatr Hematol Oncol 2007, 29:173-7.
5. Heller PG, Grinberg AR, Lencioni M, Molina MM, Roncoroni AJ: Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. Chest 1992, 102:642-3.
6. Verresen D, De Backer W, Van Meerbeeck J, Neetens I, Van Marck E, Vermeire P: Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship? Eur Respir J 1991, 4:629-31.
7. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association: ACCF/AHA 2009 expert consensus document on pulmonary hypertension: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009, 53:1573-619.
8. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP: Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004, 350:886-95. (Pubitemid 38252536)
9. Morris CR: Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematol Am Soc Hematol Educ Program 2008:177-85.
10. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT: Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002, 8:1383-9. (Pubitemid 36019423)
11. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005, 294:81-90. (Pubitemid 41002842)
12. Kato GJ, McGowan V, Machado RF, Little JA, Taylor Jt, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM Jr, Gladwin MT: Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006, 107:2279-85.
13. Kato GJ, Onyekwere OC, Gladwin MT: Pulmonary hypertension in sickle cell disease: relevance to children. Pediatr Hematol Oncol 2007, 24:159-70.
14. Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, Diwan BA, Schimel DM, Cochard AE, Wang X, Schechter AN, Noguchi CT, Gladwin MT: Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007, 109:3088-98. (Pubitemid 46482112)
15. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, Solomon SB: Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005, 115:3409-17. (Pubitemid 43121829)
16. Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES: Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 2008, 111:402-10.
17. Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ: Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007, 110:2166-72. (Pubitemid 47443936)
18. Kuypers FA: Red cell membrane lipids in hemoglobinopathies. Curr Mol Med 2008, 8:633-8.
19. Setty BN, Betal SG, Zhang J, Stuart MJ: Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia. J Thromb Haemost 2008, 6:2202-9.
20. Phrommintikul A, Sukonthasarn A, Kanjanavanit R, Nawarawong W: Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart 2006, 92:1467-72. (Pubitemid 44578845)
21. Singer ST, Kuypers FA, Styles L, Vichinsky EP, Foote D, Rosenfeld H: Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol 2006, 81:670-5.
22. De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ: Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol 2008, 83:19-25.
23. Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A, Orringer EP: Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol 2006, 134:109-15.
24. Machado RF, Anthi A, Steinberg MH, Bonds D, Sachdev V, Kato GJ, Taveira-DaSilva AM, Ballas SK, Blackwelder W, Xu X, Hunter L, Barton B, Waclawiw M, Castro O, Gladwin MT: N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 2006, 296:310-8. (Pubitemid 44079315)
25. Suell MN, Bezold LI, Okcu MF, Mahoney DH Jr, Shardonofsky F, Mueller BU: Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol 2005, 27:654-8.
26. Liem RI, Young LT, Thompson AA: Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Haematologica 2007, 92:1549-52.
27. Nelson SC, Adade BB, McDonough EA, Moquist KL, Hennessy JM: High prevalence of pulmonary hypertension in children with sickle cell disease. J Pediatr Hematol Oncol 2007, 29:334-7.
28. Dham N, Ensing G, Minniti C, Campbell A, Arteta M, Rana S, Darbari D, Nouraie M, Onyekwere O, Lasota M, Kato GJ, Gladwin MT, Castro O, Gordeuk V, Sable C: Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease. Am J Cardiol 2009, 104:713-20.
29. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, Karagiorga M: Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest 2005, 127:1523-30.
30. Hagar RW, Morris CR, Vichinsky EP: Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function. Br J Haematol 2006, 133:433-5.
31. Derchi G, Formisano F, Lamagna M, Galanello R, Bina P, Dessi A, Cappellini, Cassinerio E, Prossomariti L, Cinque P, Maggio A, Renda D, Cianciulli P, Cogliandro T, Piga A, Donato G, Forni GL: Pulmonary hypertension in thalassemia major: an Italian multicentric study. Poster presented at Ninth Cooley's Anemia Symposium: 21-24 October 2009, New York City. [http://www.nyas.org/Events/Detail.aspx?cid=9c11e73d-2349-4cdd-8910- 0d8fad184ced].
32. Hahalis G, Alexopoulos D, Kremastinos DT, Zoumbos NC: Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med 2005, 118:957-67. (Pubitemid 41297756)
33. Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, Joussef J, Rombos J, Loukopoulos D: Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 2001, 97:3411-6.
34. Lee MT, Small T, Khan MA, Rosenzweig EB, Barst RJ, Brittenham GM: Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years. Br J Haematol 2009, 146:437-41.
35. Graham JK, Mosunjac M, Hanzlick RL, Mosunjac M: Sickle cell lung disease and sudden death: a retrospective/prospective study of 21 autopsy cases and literature review. Am J Forensic Med Pathol 2007, 28:168-72. (Pubitemid 47164700)
36. Machado RF, Mack AK, Martyr S, Barnett C, Macarthur P, Sachdev V, Ernst I, Hunter LA, Coles WA, Nichols JP, Kato GJ, Gladwin MT: Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. Br J Haematol 2007, 136:319-25. (Pubitemid 46020763)
37. Atichartakarn V, Chuncharunee S, Chandanamattha P, Likittanasombat K, Aryurachai K: Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient. Blood 2004, 103:2844-6. (Pubitemid 38393049)
38. Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J, Mitilineou E, Diamanti-Kandaraki E, Meletis J, Karagiorga M: Cardiac status in well-treated patients with thalassemia major. Eur J Haematol 2004, 73:359-66.
39. Piomelli S: The splenectomy controversy. Ann N Y Acad Sci 2005, 1054:511-3.
40. Gordeuk VR, Campbell A, Rana S, Nouraie M, Niu X, Minniti CP, Sable C, Darbari D, Dham N, Onyekwere O, Ammosova T, Nekhai S, Kato GJ, Gladwin MT, Castro OL: Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. Blood 2009, 114:4639-44.
41. Minniti CP, Sable C, Campbell A, Rana S, Ensing G, Dham N, Onyekwere O, Nouraie M, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR: Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica 2009, 94:340-7.
42. Goldberg MA, Brugnara C, Dover GJ, Schapira L, Charache S, Bunn HF: Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med 1990, 323:366-72.
43. Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, Wilson RF, Bass EB, Segal JB: Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics 2008, 122:1332-42.
44. Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB: Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 2008, 148:939-55. (Pubitemid 351860826)
45. Lezcano NE, Odo N, Kutlar A, Brambilla D, Adams RJ: Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke 2006, 37:1424-6. (Pubitemid 44305720)
46. Joyce K, Sable C, Martin B, Minniti C: Pulmonary artery hypertension in children with sickle cell disease: is chronic transfusion protective? Blood 2006, 108:356a.
47. Machado RF, Martyr S, Kato GJ, Barst RJ, Anthi A, Robinson MR, Hunter L, Coles W, Nichols J, Hunter C, Sachdev V, Castro O, Gladwin MT: Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol 2005, 130:445-53. (Pubitemid 43899595)
48. Morris CR, Morris SM Jr, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP: Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003, 168:63-9.
49. Minniti CP, Machado RF, Coles WA, Sachdev V, Gladwin MT, Kato GJ: Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease. Br J Haematol 2009, 147:737-43.